Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cumberland Pharmaceuticals (CPIX) FCF Margin (2016 - 2025)

Historic FCF Margin for Cumberland Pharmaceuticals (CPIX) over the last 17 years, with Q3 2025 value amounting to 1.97%.

  • Cumberland Pharmaceuticals' FCF Margin fell 30900.0% to 1.97% in Q3 2025 from the same period last year, while for Sep 2025 it was 16.31%, marking a year-over-year increase of 206300.0%. This contributed to the annual value of 1.79% for FY2024, which is 164900.0% down from last year.
  • According to the latest figures from Q3 2025, Cumberland Pharmaceuticals' FCF Margin is 1.97%, which was down 30900.0% from 7.54% recorded in Q2 2025.
  • Cumberland Pharmaceuticals' FCF Margin's 5-year high stood at 47.42% during Q2 2023, with a 5-year trough of 25.63% in Q1 2024.
  • Its 5-year average for FCF Margin is 12.42%, with a median of 11.73% in 2023.
  • In the last 5 years, Cumberland Pharmaceuticals' FCF Margin crashed by -561800bps in 2024 and then soared by 585100bps in 2025.
  • Over the past 5 years, Cumberland Pharmaceuticals' FCF Margin (Quarter) stood at 23.45% in 2021, then soared by 77bps to 41.56% in 2022, then tumbled by -74bps to 10.6% in 2023, then soared by 72bps to 18.23% in 2024, then plummeted by -89bps to 1.97% in 2025.
  • Its last three reported values are 1.97% in Q3 2025, 7.54% for Q2 2025, and 32.88% during Q1 2025.